Download PDF
Thromb Haemost 1997; 77(06): 1218
DOI: 10.1055/s-0038-1656142
Letters to the Editor
Schattauer GmbH Stuttgart

Normal Prevalence of Factor V Leiden Gene Mutation in Patients with Severe Unstable Angina

P W H M Verheggen
1   The Department of Cardiology, Leiden University Hospital, Leiden, The Netherlands
,
B T Heymans
2   Gaubius Laboratory, TNO-PG, Leiden, The Netherlands
,
P E Slagboom
2   Gaubius Laboratory, TNO-PG, Leiden, The Netherlands
,
F Haverkate
2   Gaubius Laboratory, TNO-PG, Leiden, The Netherlands
,
V Manger Cats
1   The Department of Cardiology, Leiden University Hospital, Leiden, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 04 October 1996

Accepted after resubmission 26 February 1997

Publication Date:
12 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Bertina RM, Koeleman PBC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
    CrossrefPubMedGoogle Scholar
  • 2 Dahlbäck B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 1995; 85: 607-614
    PubMedGoogle Scholar
  • 3 Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes: Part 1 and 2. N Engl J Med 1992; 326 242-250 301-308
    PubMedGoogle Scholar
  • 4 Chesebro JH, Fuster V. Thrombosis in unstable angina. N Engl J Med 1992; 327: 192-194
    CrossrefPubMedGoogle Scholar
  • 5 Braunwald E, Jones RH, Marks DB. et al Diagnosing and managing unstable angina. Circulation 1994; 90: 613-622
    CrossrefPubMedGoogle Scholar
  • 6 Ardissino D, Gamba MG, Merlini PA, Rolla A, Barberis P, Demicheli G, Testa S, Bruno N, Specchia G. Fibrinopeptide A excretion in urine: a marker of the cumulative thrombin activity in stable versus unstable angina patients. Am J Cardiol 1991; 68: 58-63B
    CrossrefPubMedGoogle Scholar
  • 7 Merlini PA, Bauer KA, Oltrona L, Ardissino D, Cattaneo M, Belli C, Mannucci PM, Rosenberg R. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 1994; 90: 61-68
    CrossrefPubMedGoogle Scholar
  • 8 Becker RC, Cannon CP, Bovill EG, Tracy RP, Thompson B, Knatterud GL, Randall A, Braunwald E. for the TIMI III Investigators. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction. Am J Cardiol 1996; 78: 142-147
    CrossrefPubMedGoogle Scholar
  • 9 Ardissino D, Merlini PA, Gamba G, Barberis P, Demicheli G, Tests A, Colombi E, Poli A, Fetiveau R, Montemartini C. Thrombin activity an early outcome in unstable angina pectoris. Circulation 1996; 93: 1634-1639
    CrossrefPubMedGoogle Scholar
  • 10 Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85: 1504-1508
    PubMedGoogle Scholar
  • 11 Ridker PM, Hennekens CH, Lindpaintner K, Stampfer M, Eisenberg P, Miletich J. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912-917
    CrossrefPubMedGoogle Scholar
  • 12 Prohaska W, Mannebach H, Schmidt M, Gleichmann U, Kleesiek K. Evidence against heterozygous coagulation factor V 1691 G-A mutation with resistance to activated protein C being a risk factor for coronary artery disese and myocardial infarction. J Mol Med 1995; 73 (10) 521-524
    PubMedGoogle Scholar
  • 13 Ardissino D, Peyvandi F, Merlini PA, Colombi E, Mannucci PM. Factor V (Arg506-Gln) mutation in young survivors of myocardial infarction. Thromb Haemost 1996; 75: 701-702
    Article in Thieme ConnectPubMedGoogle Scholar